3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
6
Pancreatic Neoplasms
4
Neoplasms
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Pancreatitis
1
Pancreatic Diseases
1
Neoplasms, Germ Cell and Embryonal
1
Mesothelioma
1
Medulloblastoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Epilepsy
1
Ependymoma
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Temozolomide
16
Magnetic Resonance Spectroscopy
10
Etoposide
9
Cyclophosphamide
8
Radiotherapy
7
Carboplatin
7
Bevacizumab
7
Filgrastim
6
Thiotepa
5
Radiation
4
Biopsy
4
Azacitidine
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
sargramostim
3
etoposide phosphate
3
Surveys and Questionnaires
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Methotrexate
3
Irinotecan
3
Gadolinium DTPA
3
Cisplatin
3
Automobiles
3
lutetium Lu 177 dotatate
2
fluorodopa F 18
2
alovudine
2
aldesleukin
2
Yoga
2
Topotecan
2
Thalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ependymoma
×
Histocompatibility Testing
×
Clear all
NCT06323408
2025-03-25
BZKF-AYA
University Hospital Regensburg
Not yet recruiting
72 enrolled